Chemoinformaics analysis of 1-(4-AMINOBUTYL)-2-METHYLGUANIDINE
| Molecular Weight | 144.222 | nRot | 4 |
| Heavy Atom Molecular Weight | 128.094 | nRig | 9 |
| Exact Molecular Weight | 144.137 | nRing | 0 |
| Solubility: LogS | -3.619 | nHRing | 0 |
| Solubility: LogP | 7.653 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 4 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.0887 |
| nHD | 3 | BPOL | 16.6213 |
| QED | 0.364 |
| Synth | 2.727 |
| Natural Product Likeliness | 1.99 |
| NR-PPAR-gamma | 0.946 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.412 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.845 |
| MDCK | 0.0000187 |
| BBB | 0.036 |
| PPB | 0.952944 |
| VDSS | 3.644 |
| FU | 0.0502688 |
| CYP1A2-inh | 0.202 |
| CYP1A2-sub | 0.474 |
| CYP2c19-inh | 0.182 |
| CYP2c19-sub | 0.123 |
| CYP2c9-inh | 0.744 |
| CYP2c9-sub | 0.702 |
| CYP2d6-inh | 0.615 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.094 |
| CYP3a4-sub | 0.038 |
| CL | 3.23 |
| T12 | 0.269 |
| hERG | 0.048 |
| Ames | 0.002 |
| ROA | 0.277 |
| SkinSen | 0.34 |
| Carcinogencity | 0.118 |
| EI | 0.029 |
| Respiratory | 0.776 |
| NR-Aromatase | 0.073 |
| Antiviral | No |
| Prediction | 0.941324 |